RadNet, Inc. Stock Issued During Period, Value, Acquisitions
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- RadNet, Inc. stock issued during period, value, acquisitions for the quarter ending 2026-06-30 was $0.00.
- RadNet, Inc. stock issued during period, value, acquisitions for the quarter ending 2026-03-31 was $0.00.
- RadNet, Inc. stock issued during period, value, acquisitions for the quarter ending 2025-12-31 was $21.52M.
- RadNet, Inc. stock issued during period, value, acquisitions for the quarter ending 2025-09-30 was $110.72M.
- RadNet, Inc. stock issued during period, value, acquisitions for fiscal 2025 was $132.24M, a 2770.35% increase from fiscal 2024.
- RadNet, Inc. stock issued during period, value, acquisitions for fiscal 2024 was $4.61M, a 59.83% decline from fiscal 2023.
- RadNet, Inc. stock issued during period, value, acquisitions for fiscal 2023 was $11.47M, a 81.88% decline from fiscal 2022.
- RadNet, Inc. stock issued during period, value, acquisitions for fiscal 2022 was $63.31M.
| Period end | Stock Issued During Period, Value, Acquisitions 3 month | Stock Issued During Period, Value, Acquisitions 12 month |
|---|---|---|
| 2026-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-10 | $132.24M derived: sum of 4 quarters · filed 2026-08-10 |
| 2026-03-31 | $0.00 10-Q · filed 2026-05-11 | |
| 2025-12-31 | $21.52M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-02 | $132.24M 10-K · filed 2026-03-02 |
| 2025-09-30 | $110.72M 10-Q · filed 2025-11-10 | |
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-02 | $4.61M 10-K · filed 2026-03-02 |
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10 | $6.95M derived: sum of 4 quarters · filed 2026-03-02 |
| 2024-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-09 | $12.08M derived: sum of 4 quarters · filed 2026-03-02 |
| 2024-03-31 | $4.61M 10-Q · filed 2025-05-12 | $16.08M derived: sum of 4 quarters · filed 2026-03-02 |
| 2023-12-31 | $2.35M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-02 | $11.47M 10-K · filed 2026-03-02 |
| 2023-09-30 | $5.12M 10-Q · filed 2024-11-12 | |
| 2023-06-30 | $4.00M 10-Q · filed 2023-08-09 | |
| 2022-12-31 | $6.84M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-03 | $63.31M 10-K · filed 2025-03-03 |
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | |
| 2022-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-09 | |
| 2022-03-31 | $56.47M 10-Q · filed 2023-05-10 | |
| 2021-09-30 | $2.02M 10-Q · filed 2022-11-09 | |
| 2020-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-09 | |
| 2020-06-30 | $33.01M 10-Q · filed 2020-08-10 | |
| 2019-12-31 | $1.50M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | $7.50M 10-K · filed 2022-03-01 |
| 2019-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-09 | |
| 2018-12-31 | $8.00M 10-K · filed 2021-03-16 | |
| 2017-12-31 | $1.00M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-16 | $2.50M 10-K · filed 2020-03-16 |
| 2015-12-31 | $9.24M 10-K · filed 2018-03-19 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| GRAIL, Inc. (GRAL) | United States | $5.591B | -7.78 |
| VERACYTE, INC. (VCYT) | United States | $3.904B | 41.21 |
| Celcuity Inc. (CELC) | United States | $3.887B | -22.62 |
| CareDx, Inc. (CDNA) | United States | $3.174B | 13.21 |
| Caris Life Sciences, Inc. (CAI) | United States | $9.119B | 47.87 |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |
| Personalis, Inc. (PSNL) | United States | $1.769B | -13.30 |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |